Skip to content

Effect of a centella asiatica containing repair mask to skin barrier repairment after fractional laser treatment

Effect of a centella asiatica containing repair mask to skin barrier repairment after fractional laser treatment

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026523
Enrollment
Unknown
Registered
2019-10-13
Start date
2019-10-14
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin barrier repairment after fractional laser treatment

Interventions

Case series:Centella asiatica containing repair mask qd* 1 week

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University Medical School
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Subjects with skin barrier impairment after fractional laser treatment; 2. Women, between 25-55 years old; 3. Subjects should fully understand the content of trial, be willing to participate in the trial, and have signed an informed consent form; 4. Physical examination revealed no abnormality, no history of serious cardiac, hepatic, renal, digestive, neurologic, psychiatric and metabolic disease.

Exclusion criteria

Exclusion criteria: 1. The subject dose not meet the physical examination in inclusion criteria; 2. Pregnant, lactating women; 3. Be allergic to the ingredients or excipients of the trial drug; 4. Participated in any other clinical investigation within three months before the beginning of this trial; 5. Frequent user of Chinese herbal medicines, sleeping pills, sedatives, tranquilizers, or other addictive drugs; 6. Alcoholics, mental patients; or the subject can not follow doctor's advice; 7. Suffering from cardiopulmonary insufficiency or severe underlying diseases; 8. Suffering from other skin conditions that may interfere with the clinical assessment of acneiform skin evaluation and/or pose a risk to the subject, or have other serious skin disease history.

Design outcomes

Primary

MeasureTime frame
Skin lesion score;SSRI;skin dryness;skin desquamation;Comfort;

Countries

China

Contacts

Public ContactJie Zheng

Ruijin Hospital, Shanghai Jiao Tong University Medical School

jie-zheng2001@126.com+86 18917762309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026